<DOC>
	<DOCNO>NCT00049010</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure analyze surgically-removed tumor tissue lymph node sample may help doctor identify patient melanoma risk develop metastatic cancer . PURPOSE : This clinical trial study tumor tissue lymph node sample see well work predict development metastatic cancer patient stage I stage II melanoma .</brief_summary>
	<brief_title>Diagnostic Study Predict Risk Developing Metastatic Cancer Patients With Stage I Stage II Melanoma</brief_title>
	<detailed_description>OBJECTIVES : - Correlate degree melastatin gene expression risk develop local regional metastasis patient primary stage I II melanoma . - Correlate melastatin expression prospectively event-free survival patient . OUTLINE : This multicenter study . Melastatin mRNA expression determine situ hybridization use tissue primary tumor lymph node . Tissue also examine immunohistochemical stain use antibody S-100 MART-1 . Patients receive result test result influence individual therapy . Patients follow every 4 month 3.5 year . PROJECTED ACCRUAL : A total 300 patient accrue study within 3.5 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>1 . Histologically documented primary AJCC stage I II melanoma . Evidence ulceration , vertical growth phase , regression , lymphocytic infiltration , vascular invasion , microscopic satellitosis , mitotic rate shall note . 2 . Patients plan undergo sentinel lymph node biopsy , elective lymph node dissection anatomic drain region index primary melanoma . 3 . â‰¥18 year age 4 . Patients must register prior plan surgery . The surgery must perform within 45 day follow registration . 5 . No concurrent active malignancy carcinoma situ cervix basal cell carcinoma skin , history primary malignancy include previously primary melanoma . 6 . Tissue block : one primary tumor tissue take region great Breslow thickness . Note : If block send due institutional policy , slide may substitute lock per protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stage I melanoma</keyword>
	<keyword>stage II melanoma</keyword>
</DOC>